BPC-157 dosage: reported doses and schedule
An experimental repair peptide with mostly animal evidence and a few small human reports.
Also called: BPC 157, BPC157, Body protection compound 157, Bepecin, PL-14736, PCO-02.
Healing and repair peptides · Experimental synthetic pentadecapeptide.
Typical reported dose: 200–250 mcg once a day
- IV pilot: 10 mg then 20 mg: Day 1: 10 mg; day 2: 20 mg, each in 250 mL normal saline over 1 hour. once daily on two consecutive days, into a vein. Studied in a trial. Studied in: Two previously exposed adults in the 2025 safety pilot. (source)
- Under-skin daily reports: Reports and forum advice span 100-400+ mcg daily; 200-250 mcg is called average in this thread. once daily, under the skin. Reported by users, common report. Studied in: Adults reporting use online. (source)
- 250 to 500 mcg twice daily: 250 mcg twice daily for the first two weeks., then 500 mcg twice daily from week 3 through the reported seven-week course. twice daily, under the skin. Reported by users, common report. Studied in: Adults reporting use online. (source)
- Muscle-injection step-down report: 750 mcg twice daily for 1-2 weeks, then 250 mcg twice daily. twice daily, into muscle. Reported by users, rare report. Studied in: Adults reporting use online. (source)
- Oral report: two 30-day steps: Days 1-30: 250 mcg twice daily. Days 31-60: 500 mcg twice daily. twice daily, by mouth. Reported by users, occasional report. Studied in: Adults reporting use online. (source)
- Oral 500 mcg at night: 500 mcg orally at night. once daily at night, by mouth. Reported by users, occasional report. Studied in: Adults reporting use online. (source)
Highest studied: 20 mg IV over one hour on day 2 in two adults; no repeated-course safety evidence..
These are doses reported in labels, trials or user reports, not a personal plan. Check the source behind each one.
Related to BPC-157
- TB-500: A short piece of thymosin beta-4 with no proven repair benefit in humans.
- GHK-Cu: A copper-binding skin peptide with small topical studies and untested systemic injections.
- AHK-Cu: A copper peptide used in scalp serums, with laboratory findings and weak patent-only human data.
- Thymosin beta-4: A peptide studied for eye conditions and skin wounds; tendon-repair injections lack controlled human evidence.
- ARA-290: Experimental peptide studied for small-fiber nerve damage, with uncertain pain relief and safety.
- Ac-SDKP: An experimental repair peptide with old human studies, but no proven healing dose.
Sources
- 21 CFR 216.23 — Bulk drug substances that can be used to compound drug products in accordance with section 503A of the Federal Food, Drug, and Cosmetic Act., Office of the Federal Register · eCFR · 2026
- 503B Bulk Drug Substances List, FDA · FDA · 2026
- Certain Bulk Drug Substances for Use in Compounding that May Present Significant Safety Risks, FDA · FDA · 2026
- Federal Register: nonbinding draft HHS interim policy, October 30 2026, 2026
- GHK-Cu & BPC-157 powder: Unauthorized active pharmaceutical ingredients, Health Canada · 2026
- HHS 503A peptide interim enforcement policy and conditions, October 30 2026, 2026
- July 23-24, 2026, Meeting of the Pharmacy Compounding Advisory Committee – FDA Briefing Document for BPC-157-Related Bulk Drug Substances (BPC-157 (free base) and BPC-157 acetate), FDA · 2026
- July 23-24, 2026: Meeting of the Pharmacy Compounding Advisory Committee - 07/23/2026, FDA · FDA · 2026
- Sepsis, NHS · 2026
- The 2026 Prohibited List, World Anti-Doping Agency · WADA · 2026
- Think twice before injecting peptides bought online: unauthorized products can seriously harm you, Health Canada · Health Canada · 2026
- Notice of final decisions to amend (or not amend) the current Poisons Standard (November 2023), Therapeutic Goods Administration · 2024
- Anaphylaxis, NHS · NHS · 2023
- Fraudulent Coronavirus Disease 2019 (COVID-19) Products, FDA · 2020
- Anticoagulant medicines - Considerations, NHS
Sources checked: 2026-10-18.
Information only, not medical advice. Peptifacts does not sell anything and does not link to sellers.